Fisher-Price Recalls 2 Million Infant Snuga Swings Due to Safety Concerns

Fisher-Price has announced the recall of over 2 million infant Snuga Swings following reports of five infant deaths linked to suffocation risks. The U.S. Consumer Product Safety Commission (CPSC) issued an alert, emphasizing that the swings, which retail for around $160, “should never be used for sleep” and cautioning against adding bedding materials, which can heighten the risk of suffocation.

The fatalities, reported between 2012 and 2022, involved infants aged 1 to 3 months who were reportedly unrestrained and using the swings for sleep, often with bedding materials present. The American Academy of Pediatrics recommends that sleep spaces remain free of loose blankets, pillows, and soft toys to mitigate suffocation hazards.

Pic Credit: Amazon

This recall affects all 21 models of Snuga Swings sold across the United States, Canada, and Mexico since 2010, with distribution through major retailers including Amazon, Toys R Us, Target, Walmart, and Sam’s Club.

In response to the recall, Fisher-Price advises consumers to immediately remove the headrest and body support insert from the swing. To facilitate this, the company is offering a $25 refund for those who comply, which can be processed through Mattel’s website.

However, Richard Trumka Jr., a commissioner at the CPSC, criticized the recall for not including the entire product. He expressed concerns that the modified swings would still pose a safety risk, urging consumers to discard the product entirely after claiming the refund.

This is not the first time Fisher-Price has faced scrutiny over infant safety; the company has previously recalled its Rock ‘n Play Sleepers after multiple reports of infant fatalities.

Consumers seeking further information on the recall and affected model numbers are encouraged to visit the CPSC website.

Hot this week

Flu Wave Hits Southeast Asia, Highlighting Gaps in Protection for the Elderly

Many countries in Asia are reporting a sharp rise...

From Burnout to Breakthroughs: Agentforce Redefines Life Sciences Customer Engagement

Built on Salesforce’s trusted platform, Agentforce Life Sciences introduces...

Health Biotech Strengthens Global Footprint at CPHI Frankfurt 2025

Health Biotech Limited (Health Biotech), a research and development-driven...

Robotic Knee Replacement: A Game-Changer for Pain-Free Mobility

For many, knee pain is more than just discomfort...

A New Dawn for Arthritis: New Treatment Options to Reclaim Your Mobility

Osteoarthritis (OA) is the most common type of arthritis....

Topics

Flu Wave Hits Southeast Asia, Highlighting Gaps in Protection for the Elderly

Many countries in Asia are reporting a sharp rise...

From Burnout to Breakthroughs: Agentforce Redefines Life Sciences Customer Engagement

Built on Salesforce’s trusted platform, Agentforce Life Sciences introduces...

Health Biotech Strengthens Global Footprint at CPHI Frankfurt 2025

Health Biotech Limited (Health Biotech), a research and development-driven...

Robotic Knee Replacement: A Game-Changer for Pain-Free Mobility

For many, knee pain is more than just discomfort...

A New Dawn for Arthritis: New Treatment Options to Reclaim Your Mobility

Osteoarthritis (OA) is the most common type of arthritis....

SMT's Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

Sahajanand Medical Technologies (SMT) announced significant new findings from...

Spine 360 Brings World-Class Spine Care to South Bangalore

Spine 360 — a leader in advanced spinal healthcare...

Sachidanand Upadhyay Joins Global Business Elite with Second Appearance in Time Magazine

Sachidanand Upadhyay, Managing Director of Lord’s Mark Industries Ltd....

Related Articles

Translate »